A pilot study of the medroxyprogesterone + metformin combination therapy for the endometrial cancer

Not Applicable

• Conditions: endometrial cancer atypical endometrial hyperplasia

• Registration Number: JPRN-UMIN000002210
• Lead Sponsor: chiba university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-07-16
• Study Completion: 2014-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

(1) The case with a history of the hypersensitivity that is serious for this study use medicine or the drug allergy (2)A history of the lactic acidosis (3)Patients on dialysis (4)Shock, failure heart, myocardial infarction, a cardiovascular injury including the pulmonary embolism (5)Excessive alcohol intake (6)Hepatic dysfunction (7) A history of the thrombosis (8)A case with the psychic disturbance that it seems that we need in the treatment or treatment with antimental medicine (9) Patients with diabetes (10)A case with the double cancer of the activity (11)In addition, the case that the chief physician judged to be inadequate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified